Drawing for LEON ENABLING NANO NOW

USPTO serial 79299299

LEON ENABLING NANO NOW

Reviewed by CopyMark Law Group

Filing date
Status date
Registration date
Examiner
AGREDA, SAMANTHA LEIGH
Law office
TMO LAW OFFICE 123 - EXAMINING ATTORNEY ASSIGNED

What this means

These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.

Status 602: These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances.

Need help with LEON ENABLING NANO NOW?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
005Pharmaceutical preparations; chemical preparations for medical purposes; adjuvants for medical purposes; chemical preparations, namely, nanoparticles for pharmaceutical purposes; chemical preparations, namely, nanoparticles for medical purposesACTIVE
042Scientific research; pharmaceutical research and development services; laboratory research services relating to pharmaceuticals; working on and evaluation of chemical syntheses; pharmaceutical product evaluation; consultancy related to pharmaceutical research and development; product development consultancy in the field of nanotechnology; product development consultancy; industrial product development; conducting clinical trials for pharmaceutical products; materials testing and evaluation; testing, authentication and quality controlACTIVE

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Apr 30, 2026NREPNEW REPRESENTATIVE AT IB RECEIVED
Oct 2, 2022FINTFINAL DECISION TRANSACTION PROCESSED BY IB
Sep 13, 2022FICSFINAL DISPOSITION NOTICE SENT TO IB
Sep 13, 2022FICRFINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
May 23, 2022OPNXNOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
May 4, 2022OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
May 4, 2022OPNRNOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Sep 13, 2021MAB2ABANDONMENT NOTICE MAILED - FAILURE TO RESPONDThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Sep 13, 2021ABN2ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSEThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Mar 22, 2021RFNTREFUSAL PROCESSED BY IB
Mar 2, 2021RFCSNON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Mar 2, 2021RFRRREFUSAL PROCESSED BY MPU
Feb 24, 2021RFCRNON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Feb 23, 2021CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 15, 2021DOCKASSIGNED TO EXAMINER
Dec 8, 2020MAFRAPPLICATION FILING RECEIPT MAILED
Dec 4, 2020NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Dec 3, 2020REPRSN ASSIGNED FOR SECT 66A APPL FROM IB

Frequently asked questions

Related guidance